J&J | Le Bénéfice D'Exploitation



Operating Profit Changement Date
AbbVie USD 3.73B 5.22B 2025-03
Abbott USD 1.66B 253M 2025-03
Amgen USD 1.29B 1.02B 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
Baxter International USD -435000000 590M 2024-12
Bayer EUR 2.32B 1.21B 2025-03
Becton, Dickinson and Co. USD 546M 93M 2025-03
Biogen USD 311.2M 130.2M 2025-03
Boston Scientific USD 921M 246M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
CONMED USD 15.96M 36.54M 2025-03
Cooper Companies USD 182M 16.4M 2025-01
Dexcom USD 133.7M 55.2M 2025-03
Edwards Lifesciences USD 394.8M 82.2M 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Globus Medical USD 97M 36.73M 2025-03
Hologic USD -7000000 236.8M 2025-03
Indivior 66M 226M 2025-03
Insulet USD 49.3M 60M 2025-03
Integra LifeSciences USD -15961000 51.19M 2025-03
Intuitive Surgical USD 578.1M 156.8M 2025-03
J&J USD 13.63B 9.74B 2025-03
Medtronic USD 1.44B 210M 2025-04
Merck USD 5.87B 1.57B 2025-03
Merit Medical Systems USD 41.03M 4.47M 2025-03
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
Stryker USD 837M 256M 2025-03
Tandem Diabetes Care USD -120878000 120.3M 2025-03
Teva Pharmaceutical Industries USD 519M 64M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12
Zimmer Biomet Holdings USD 389M 109.5M 2024-12
Zoetis USD 810M 78M 2025-03



J&J Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.